Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

IOSP earnings analysis

Filed May 8, 2026 · Our reading of the company's report

The latest report

Innospec (IOSP) reported strong Q1 2026 performance, exceeding estimates with revenue of $453.2 million and EPS of $1.05. Both metrics showed year-over-year growth partly driven by strong Fuel Specialties sales despite…

Read full summary

Innospec (IOSP) reported strong Q1 2026 performance, exceeding estimates with revenue of $453.2 million and EPS of $1.05. Both metrics showed year-over-year growth partly driven by strong Fuel Specialties sales despite adverse weather impacts on Performance Chemicals. The company anticipates continued sequential growth in the coming quarter, though it faces some challenges related to operating expenses and foreign exchange rates.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

31% Gross margin Operating margin Aug 2023 May 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

From revenue to operating profit

Where each $100 of revenue went in this report.

Of every $100 of revenue Cost of sales $73 Operating expenses $19 Left as operating profit $8

Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Aug 2023 May 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$1.05
Segment
Performance Chemicals
Segment
Fuel Specialties
Segment
Oilfield Services

What stood out

  • Revenue Growth Exceeds Estimates

    Q1 2026 revenue reached $453.2 million, a 3% increase from $440.8 million in Q1 2025, surpassing estimates by 4.87%.

  • Positive EPS Surprise

    Reported EPS for Q1 2026 stood at $1.05, exceeding the estimate of $1.01, reflecting a surprise of 3.96%.

  • Fuel Specialties Segment Up 7%

    Fuel Specialties revenue increased to $181.6 million in Q1 2026, up from $170.3 million in Q1 2025, representing a 7% growth.

  • Cash Generation from Operations

    Operating cash flow was $17.6 million for Q1 2026, albeit down from $28.3 million in Q1 2025.

  • Stable Cash Position

    Cash and cash equivalents remained relatively stable at $289.1 million as of March 31, 2026, compared to $292.5 million at year-end 2025.

  • Adjusted Working Capital Increased

    Adjusted working capital rose by $20.1 million compared to the previous quarter, resulting in a total adjusted working capital of $384.8 million.

What to watch

  • Decreased Gross Profit

    Gross profit declined to $123.5 million in Q1 2026 from $125.1 million in Q1 2025, a decrease of 1.3%.

  • Increased Corporate Costs

    Corporate costs rose by 26% year-over-year to $22.3 million, reflecting higher legacy costs and legal expenses.

  • Negative Impact from Winter Weather

    Performance Chemicals segment saw net sales of $169.4 million, a marginal increase but significantly impacted by 15% lower volumes due to winter weather disruptions.

Management's outlook

Company expressed optimism for sequential growth in Q2 2026, but specific guidance figures were not provided.

Earlier filings 4

10-K · February 18, 2026

Innospec’s 2025 Form 10-K emphasizes a three-segment specialty chemicals strategy (Performance Chemicals, Fuel Specialties, Oilfield Services) focused on new product development, selective M&A and geographic expansion.…

10-Q · November 5, 2025

Innospec’s Q3 2025 results showed revenue essentially flat at $441.9 million (Q3 2024: $443.4M) but operating profit and EPS collapsed due to non‑recurring and impairment charges. The company recorded impairments of…

10-Q · May 9, 2025

Innospec reported Q1 net sales of $440.8 million (Q1 2024: $500.2M), with gross profit of $125.1 million and net income of $32.8 million. Revenue and margins contracted year-over-year; operating cash flow weakened to…

10-K · February 19, 2025

Innospec continues to position itself as a focused specialty chemicals group operating three reportable segments (Performance Chemicals, Fuel Specialties and Oilfield Services) and is investing in R&D and selective M&A…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.